D. E. Shaw & Co »

Inhibrx Biosciences shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.7M 100k 67.23
2025-12-31 $11M 145k 79.00
2025-09-30 $389k 12k 33.68

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C Call Option (GOOG)
Micron Technology Put Option (MU)
Meta Platforms Cl A Call Option (META)
Amazon (AMZN)
Boston Scientific Corporation Call Option (BSX)
Advanced Micro Devices Put Option (AMD)
Taiwan Semiconductor Manufac Sponsored Ads Call Option (TSM)
JPMorgan Chase & Co. Call Option (JPM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for D. E. Shaw & Co

Top funds holding Inhibrx Biosciences

Perceptive Advisors
Viking Global Investors
Morgan Stanley
Sanofi
HighTower Advisors
BlackRock
Susquehanna International
Vanguard Group
Vanguard Capital Management
Caligan Partners
Sofinnova Ventures
Capital Research Global Investors
Woodline Partners
State Street Corporation
Millennium Management

View all funds holding Inhibrx Biosciences